Erratum

Digestion 2003;67:118–128 Netzer/Halter/Ma/Hoa/Nguyen/Nakamura/ Tarnawski 39 Takahashi M, Ota S, Shimada T, Hamada E, Kawabe T, Okudaira T, Matsumura M, Kaneko N, Terano A, Nakamura T, Omata M: Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture. J Clin Invest 1995;95:1994–2003. 40 Watanabe S, Hirose M, Wang XE, Maehiro K, Murai T, Kobayashi O, Nagahara A, Sato N: Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells. Biochem Biophys Res Commun 1994;199: 1453–1460. 41 Dignass AU, Lynch-Devaney K, Podolsky DK: Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 1994;202:701–709. 42 Szabo IL, Pai R, Jones MK, Ehring GR, Kawanaka H, Tarnawski AS: Indomethacin delays gastric restitution: Association with the inhibition of focal adhesion kinase and tensin phosphorylation and reduced actin stress fibers. Exp Biol Med (Maywood) 2002;227:412–424. 43 Wallace JL, Granger DN: The cellular and molecular basis of gastric mucosal defense. FASEB J 1996;10:731–740. 44 Lacy ER, Ito S: Rapid epithelial restitution of the rat gastric mucosa after ethanol injury. Lab Invest 1984;51:573–583. 45 Kaur P, Potten CS: Cell migration velocities in the crypts of the small intestine after cytotoxic insult are not dependent on mitotic activity. Cell Tissue Kinet 1986;19:601–610. 46 Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M: Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997;112:387–397. 47 Kishimoto Y, Wada K, Nakamoto K, Kawasaki H, Hasegawa J: Levels of cyclooxygenase-1 and -2 mRNA expression at various stages of acute gastric injury induced by ischemia-reperfusion in rats. Arch Biochem Biophys 1998; 352:153–157. 48 DuBois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LBA, Lipsky PE: Cyclooxygenase in biology and disease. FASEB J 1998;12:1063–1073. 49 Ukawa H, Yamakuni H, Kato S, Takeuchi K: Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Dig Dis Sci 1998;43: 2003–2011. 50 Bamba H, Ota S, Kato A, Matsuzaki F: Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem Biophys Res Commun 1998;245:567–571. 51 Brzozowski T, Konturek PC, Konturek SJ, Pajdo R, Schuppan D, Drozdowicz D, Ptak A, Pawlik M, Nakamura T, Hahn EG: Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor. J Physiol Pharmacol 2000;51:751–773. 52 Takahashi M, Katayama Y, Takada H, Kuwayama H, Terano A: The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts. Aliment Pharmacol Ther 2000; 14(suppl 1):44–49. 53 Spenney JG, Bhown M: Effect of acetylsalicylic acid on gastric mucosa. II. Mucosal ATP and phosphocreatine content, and salicylate effects on mitochondrial metabolism. Gastroenterology 1977;73:995–999. 54 Mahmud T, Scott DL, Bjarnason I: A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity. Ann Rheum Dis 1996;55:211–213. 55 Somasundaram S, Hayllar H, Rafi S, Wrigglesworth JM, Macpherson AJ, Bjarnason I: The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: A review and a hypothesis. Scand J Gastroenterol 1995;30:289–299.